Assessing the utility of a cell-free tumor (ct)DNA assay (MSK-ACCESS) in patients (pts) with node-positive (N+) muscle-invasive bladder cancer (MIBC) undergoing neoadjuvant chemotherapy (NAC).

Authors

null

Andrew B Katims

Memorial Sloan Kettering Cancer Center, New York, NY

Andrew B Katims , Andrew T Lenis , Ronak H. Shah , Carissa E Chu , Neha Ratna , Ashley M Regazzi , Eugene J. Pietzak , David H Aggen , Samuel A Funt , Min Yuen Teo , Jonathan E. Rosenberg , Dean F. Bajorin , Timothy F. Donahue , Bernard H. Bochner , Michael F. Berger , David B. Solit , Gopa Iyer

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer - Advanced

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 544)

DOI

10.1200/JCO.2023.41.6_suppl.544

Abstract #

544

Poster Bd #

M7

Abstract Disclosures

Similar Posters

First Author: Benjamin Miron

Poster

2014 Genitourinary Cancers Symposium

Somatic genomic alterations in urothelial cancer: Results of the Cancer Genome Atlas (TCGA) bladder cancer (BC) analysis.

Somatic genomic alterations in urothelial cancer: Results of the Cancer Genome Atlas (TCGA) bladder cancer (BC) analysis.

First Author: Jonathan E. Rosenberg

First Author: Ajitha Kommalapati